Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Natural history of progression after PSA elevation following radical prostatectomy.

Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC.

JAMA. 1999 May 5;281(17):1591-7.

PMID:
10235151
2.

Markers and meaning of primary treatment failure.

Swindle PW, Kattan MW, Scardino PT.

Urol Clin North Am. 2003 May;30(2):377-401. Review.

PMID:
12735513
3.

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Han M, Partin AW, Pound CR, Epstein JI, Walsh PC.

Urol Clin North Am. 2001 Aug;28(3):555-65. Review.

PMID:
11590814
4.

[PSA and follow-up after treatment of prostate cancer].

Benchikh El Fegoun A, Villers A, Moreau JL, Richaud P, Rebillard X, Beuzeboc P.

Prog Urol. 2008 Mar;18(3):137-44. doi: 10.1016/j.purol.2007.12.010. Epub 2008 Apr 18. Review. French.

PMID:
18472065
5.

Prostate specific antigen only progression of prostate cancer.

Moul JW.

J Urol. 2000 Jun;163(6):1632-42. Review.

PMID:
10799151
6.
7.

Variables in predicting survival based on treating "PSA-only" relapse.

Moul JW.

Urol Oncol. 2003 Jul-Aug;21(4):292-304. Review.

PMID:
12954500
8.

Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failure.

Meyer F, Moore L, Bairati I, Lacombe L, Têtu B, Fradet Y.

J Urol. 1999 Dec;162(6):2024-8. Review.

PMID:
10569561
9.

PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium.

Djavan B, Moul JW, Zlotta A, Remzi M, Ravery V.

Eur Urol. 2003 Jan;43(1):12-27. Review.

PMID:
12507539
10.

Disease recurrence after radical prostatectomy. Contemporary diagnostic and therapeutical strategies.

Augustin H, Hammerer PG.

Minerva Urol Nefrol. 2003 Dec;55(4):251-61. Review.

PMID:
14765017
11.

Management of patients with an increasing prostate-specific antigen after radical prostatectomy.

Khan MA, Partin AW.

Curr Urol Rep. 2004 Jun;5(3):179-87. Review.

PMID:
15161566
12.
13.

[Prostate cancer recurrence after radical prostatectomy and salvage radiotherapy].

Ojea Calvo A, Pérez Rodríguez A, Domínguez Freire F, Alonso Rodrigo A, Rodríguez Iglesias B, Benavente Delgado J, Barros Rodríguez JM, González Piñeiro A, Otero García M, Muñoz Garzón V.

Actas Urol Esp. 2004 Nov-Dec;28(10):743-8. Review. Spanish.

PMID:
15666516
14.
15.

Rising PSA after a radical treatment.

Carroll P.

Eur Urol. 2001;40 Suppl 2:9-16. Review.

PMID:
11684859
16.

What does prostate-specific antigen recurrence mean?

Pound CR, Partin AW.

Curr Urol Rep. 2000 May;1(1):28-35. Review.

PMID:
12084338
17.

Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy.

Ruckle HC, Klee GG, Oesterling JE.

Mayo Clin Proc. 1994 Jan;69(1):69-79. Review.

PMID:
7505870
18.

[False Elevation of Prostate-Specific Antigen Caused by Heterophilic Antibody Interference after Radical Prostatectomy : A Case Report].

Kamiyama Y, Somiya S, Fujikawa S, Yamada Y, Tamaki M, Kanaoka T, Hayashi T.

Hinyokika Kiyo. 2017 Oct;63(10):435-437. doi: 10.14989/ActaUrolJap_63_10_435. Review. Japanese.

PMID:
29103259
19.

Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature.

Grisanti S, Antonelli A, Buglione M, Almici C, Foroni C, Sodano M, Triggiani L, Greco D, Palumbo C, Marini M, Magrini SM, Berruti A, Simeone C.

Anticancer Res. 2016 Jun;36(6):2975-81. Review.

PMID:
27272813
20.

Supplemental Content

Support Center